Lab
Neogenomics Laboratories INC
Neogenomics Laboratories INC was paid $4.73M by Medicaid between Jan 2018 and Oct 2024, across 56 billing codes. Its largest line is 88374, — 39% of everything it billed.
33Billing provider infoNEOGENOMICS LABORATORIES INC
JUNO BEACH, FL 33408
JUNO BEACH, FL 33408
33aNPI1073549663assigned 06/24/2006
33bProvider typeClinical Medical Laboratory
28Total paid$4.73M
24GClaims81,845
24DCodes billed56
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#15 of 225
Median peer was paid$74K
This provider vs. median64×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SHERMAN, JEFFREY controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,851 | $611K | |
| 2019 | 13,751 | $902K | |
| 2020 | 18,562 | $1.10M | |
| 2021 | 23,094 | $1.30M | |
| 2022 | 11,396 | $516K | |
| 2023 | 3,516 | $207K | |
| 2024incomplete | 1,675 | $96K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88374 | 39% | 19,410 | 10,527 | $1.83M | |
| 88185 | 29% | 11,388 | 8,155 | $1.39M | |
| 88184 | 6.6% | 9,176 | 8,158 | $314K | |
| 88237 | 4.7% | 5,217 | 3,568 | $223K | |
| 88341 | 4.2% | 3,468 | 3,008 | $201K | |
| 88377 | 3.7% | 2,673 | 1,884 | $174K | |
| 88361 | 2.8% | 2,890 | 2,384 | $132K | |
| 88189 | 2.3% | 4,867 | 4,433 | $110K | |
| 88342 | 1.9% | 7,114 | 6,320 | $89K | |
| 88264 | 1.5% | 1,646 | 1,532 | $72K | |
| 88360 | 1.5% | 3,578 | 2,899 | $69K | |
| 88291 | <1% | 5,742 | 5,345 | $38K |
44 more codes
| 88121 | <1% | 224 | $17K | |
| 88313 | <1% | 720 | $12K | |
| 81455 | <1% | 38 | $11K | |
| 88120 | <1% | 86 | $10K | |
| 88365 | <1% | 242 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 450 | $6K |
| 85060 | <1% | 354 | $5K | |
| 85097 | <1% | 239 | $5K | |
| 88323 | <1% | 140 | $4K | |
| 81206 | <1% | 288 | $4K | |
| 81270 | <1% | 197 | $2K | |
| 88364 | <1% | 50 | $2K | |
| 81279 | <1% | 74 | $2K | |
| 88182 | <1% | 51 | $1K | |
| 81207 | <1% | 163 | $1K | |
| 88311 | <1% | 416 | $855.01 | |
| 88188 | <1% | 13 | $400.14 | |
| 81403 | <1% | 28 | $382.40 | |
| 88280 | <1% | 14 | $193.29 | |
| 81479 | Unlisted molecular pathology procedure | <1% | 12 | $160.68 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 13 | $0.00 |
| 84439 | 0% | 17 | $0.00 | |
| 82570 | 0% | 22 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 24 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 61 | $0.00 |
| 80061 | Lipid panel | 0% | 76 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 19 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 31 | $0.00 |
| 86803 | 0% | 14 | $0.00 | |
| 81001 | 0% | 29 | $0.00 | |
| 82607 | 0% | 15 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 144 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 24 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 41 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 60 | $0.00 |
| 82043 | 0% | 20 | $0.00 | |
| 86592 | 0% | 17 | $0.00 | |
| 82746 | 0% | 12 | $0.00 | |
| 80050 | General health panel | 0% | 32 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 33 | $0.00 |
| 85027 | 0% | 26 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 14 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 75 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 58 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHERMAN, JEFFREY (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Neogenomics Laboratories INC | Aliso Viejo, CA | $21.49M |
| Neogenomics Laboratories INC | Ramsey, NJ | $3.05M |
| Neogenomics Laboratories INC | Fort Myers, FL | $2.33M |
| Neogenomics Laboratories INC | Carlsbad, CA | $1.42M |
| Neogenomics Laboratories INC | Houston, TX | $433K |
| Neogenomics Laboratories INC | Fresno, CA | $394K |
| Neogenomics Laboratories INC | Nashville, TN | $23K |
| Neogenomics Laboratories INC | Sierra Madre, CA | $15K |
| Neogenomics Laboratories INC | Temple Terrace, FL | $12K |
| Neogenomics Laboratories INC | Houston, TX | $2K |
| Neogenomics Laboratories INC | Troy, MI | $784.07 |
| Neogenomics Laboratories INC | Scottsdale, AZ | $704.18 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.